Contact

About Us

Making human biology the foundation of modern medicine

For decades, drug development has relied on models that don’t look or act like humans. More than 90% of drugs that enter clinical trials fail in humans not necessarily because the science is wrong, but because the drugs were developed and tested in animal models poorly representative of human biology.

CapyBio was founded to fix that problem. We empower development of the next-gen human cell models for research, drug development, and more.

Regulatory agencies around the world are accelerating the shift away from animal testing, reshaping how new drugs are developed and validated.

FDA
NIH
UK

Why do current cell models fall short?

Conventional approaches either lose identity or fail to scale

We understand this problem deeply, and are working hard to build
a platform that makes scalable, high-fidelity human cells a reality.

Meet Our
Leadership Team

Eric Gornstein, MBA

CEO

Sam Morris, PhD

Co-Founder

Guillermo Rivera, PhD

Co-Founder, CSO

Kunal Jindal, PhD

Co-Founder, CTO


Board of Directors

David Smoller, PhD

Board Director

Tom Cohen, PhD

Board Director

James McCarter, MD PhD

Board Director

Carter Cliff, PhD

Board Director

Contact